Fidelity Investments
ROIV icon

Fidelity Investments’s Roivant Sciences ROIV Stock Holding History

Fidelity Investments’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.87B Buy
81,020,390
+3,039,137
+4% +$89.8M 0.12% 133
2026
Q1 		$2.16B Buy
77,981,253
+12,201,789
+19% +$313M 0.11% 152
2025
Q4 		$1.43B Buy
65,779,464
+5,012,480
+8% +$98.9M 0.07% 215
2025
Q3 		$919M Buy
60,766,984
+5,257,703
+9% +$65.1M 0.05% 313
2025
Q2 		$626M Buy
55,509,281
+3,842,770
+7% +$41.7M 0.04% 408
2025
Q1 		$521M Buy
51,666,511
+2,364,928
+5% +$25.6M 0.03% 434
2024
Q4 		$583M Buy
49,301,583
+156,527
+0.3% +$1.85M 0.03% 420
2024
Q3 		$567M Buy
49,145,056
+2,593,910
+6% +$29.5M 0.03% 432
2024
Q2 		$492M Buy
46,551,146
+11,210,583
+32% +$123M 0.03% 451
2024
Q1 		$372M Sell
35,340,563
-1,635,685
-4% -$17.6M 0.03% 552
2023
Q4 		$415M Sell
36,976,248
-1,934,377
-5% -$18.9M 0.03% 470
2023
Q3 		$454M Buy
38,910,625
+2,913,491
+8% +$32.9M 0.04% 420
2023
Q2 		$363M Buy
35,997,134
+5,234,850
+17% +$46.8M 0.03% 511
2023
Q1 		$227M Buy
30,762,284
+390,794
+1% +$3.22M 0.02% 662
2022
Q4 		$243M Buy
30,371,490
+26,196,460
+627% +$146M 0.02% 619
2022
Q3 		$13.4M Buy
4,175,030
+1,675,030
+67% +$6.49M ﹤0.01% 1772
2022
Q2 		$10.2M Hold
2,500,000
– – ﹤0.01% 1957
2022
Q1 		$12.3M Hold
2,500,000
– – ﹤0.01% 2028
2021
Q4 		$25.2M Buy
+2,500,000
New +$20.8M ﹤0.01% 1714

Other funds holding ROIV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments's ROIV Position: Q2 2026 in Review

Fidelity Investments increased its Roivant Sciences (ROIV) stake by 3.9% in Q2 2026, buying an estimated $89.8M and bringing the position to 81,020,390 shares worth $2.87B. The position accounts for 0.12% of the portfolio, ranked #133.

Fidelity Investments first reported a position in ROIV in Q4 2021 and has held it in 19 quarters since. 497 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Fidelity Investments held 81,020,390 shares of Roivant Sciences worth $2.87B as of Q2 2026.
  • Fidelity Investments bought 3,039,137 Roivant Sciences shares in Q2 2026, an estimated $89.8M.
  • Roivant Sciences made up 0.12% of Fidelity Investments's portfolio in Q2 2026, its #133 holding.
  • Fidelity Investments first reported a position in Roivant Sciences in Q4 2021 and has held it in 19 quarters since.
  • 497 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.